Daily Coverage Las Vegas 2015

You are watching a 25-second preview
Log in to keep watching

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

  • Bookmark
  • Share this Video

Anti-VEGF with Targeted PRP

by David M. Brown, MD, Jonathan L. Prenner, MD

Jonathan Prenner, MD, interviews David M. Brown, MD, about a DAVE trial in which researchers used targeted PRP in combination with anti-VEGF therapy to improve outcomes in patients with DME. Researchers hypothesized that by targeting VEGF-producing tissue, one could reduce treatment burden. Dr. Brown compares visual acuity outcomes in patients with anti-VEGF therapy and PRP with patients receiving anti-VEGF monotherapy.

6,957 video views since .  103,852 total series views.

These programs are not affiliated with the official program of AAO 2015.

Comments (0)